← Leaderboards
Michael G Curley
E.P., Ltd
$14,599,733
Attributed
$14,599,733
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,599,733 · 4
By mechanism
R44$14,599,733 · 4
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Saline”
- Xinhua Li · Nano Terra, Inc.$27,128,337
- Myron D Ginsberg · University Of Miami School Of Medicine$18,278,885
- Joren C Madsen · Massachusetts General Hospital$14,651,285
- Steven C Pennings · University Of Georgia Research Foundation Inc$12,997,622
- Keri Hammel · The Emmes Company, Llc$11,933,187
- Dennis A Hansell · Bermuda Institute Of Ocean Sciences (Bios), Inc.$10,875,960
Research focus
SalineLiver NeoplasmsElectrodesBiomaterial CompatibilitySterilityAblationRadiofrequency Interstitial AblationTissuesSafetyUnited StatesMyocardiumClinical TrialsLesionAneurysmQuality Of LifeClinical ResearchImplantPerforationArrhythmiaEffusionAnti-Arrhythmia AgentsMonitorCathetersDefibrillators
Grant awards (15)
Eliminating Ventricular Tachycardia: Pivotal Clinical Trial using the Durablate® Catheter$437,984
R44 · FY2025 · HL · contact PI
Eliminating Ventricular Tachycardia: Pivotal Clinical Trial using the Durablate® Catheter$1,210,431
R44 · FY2024 · HL · contact PI
Eliminating Ventricular Tachycardia: Pivotal Clinical Trial using the Durablate® Catheter$1,342,339
R44 · FY2023 · HL · contact PI
Eliminating Ventricular Tachycardia: First in Human Clinical Trial using the Durablate⢠Catheter$1,160,843
R44 · FY2018 · HL · contact PI
Eliminating Ventricular Tachycardia: First in Human Clinical Trial using the Durablate⢠Catheter$1,673,144
R44 · FY2017 · HL · contact PI
Novel Catheter for Treatment of Ventricular Tachycardia$1,189,143
R44 · FY2010 · HL · contact PI
Novel Catheter for Treatment of Ventricular Tachycardia$1,185,803
R44 · FY2009 · HL · contact PI
Novel Catheter for Treatment of Ventricular Tachycardia$1,304,033
R44 · FY2008 · HL · contact PI
Saline Enhanced Radiofrequency Ablation for Liver Tumors$945,936
R44 · FY2008 · CA · contact PI
Saline Enhanced Radiofrequency Ablation for Liver Tumors$1,030,412
R44 · FY2007 · CA · contact PI
Saline Enhanced Radiofrequency Ablation for Liver Tumors$1,004,711
R44 · FY2006 · CA · contact PI
Novel Catheter for Treatment of Ventricular Tachycardia$533,907
R44 · FY2003 · HL
Novel Catheter for Treatment of Ventricular Tachycardia$601,573
R44 · FY2002 · HL
SALINE ENHANCED RADIOFREQUENCY ABLATION FOR LIVE TUMORS$504,075
R44 · FY2001 · CA
SALINE ENHANCED RADIOFREQUENCY ABLATION FOR LIVER TUMORS$475,399
R44 · FY2000 · CA